Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2026-03-03 @ 2:42 PM
Study NCT ID:
NCT03939533
Status:
COMPLETED
Last Update Posted:
2023-11-07
First Post:
2019-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
Sponsor:
Octapharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SCGAM-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None